BS
AGN

Banco Santander’s Allergan plc AGN Stock Holding History

Banco Santander’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100,000
Closed -$17.7M – 439
2020
Q1 		$17.7M Buy
+100,000
New +$18.8M 0.2% 75
2019
Q1 		– Sell
-38,650
Closed -$5.17M – 407
2018
Q4 		$5.17M Hold
38,650
– – 0.07% 143
2018
Q3 		$7.36M Hold
38,650
– – 0.08% 131
2018
Q2 		$6.44M Buy
+38,650
New +$6.2M 0.08% 128

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Banco Santander's AGN Position: Q2 2020 in Review

Banco Santander sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 100,000 shares — an estimated $17.7M sold.

Banco Santander first reported a position in AGN in Q2 2018 and held it in 4 quarters. The position peaked at $17.7M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Banco Santander reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Banco Santander sold 100,000 Allergan plc shares in Q2 2020, an estimated $17.7M.
  • Banco Santander first reported a position in Allergan plc in Q2 2018 and held it in 4 quarters.
  • Banco Santander's Allergan plc position peaked at $17.7M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Banco Santander's 13F filing for Q2 2020, filed 5 Aug 2020.